GLP-1 Weight Loss Drugs Linked to Scurvy Risk, Veterinary Research Expands to Cats
New research links GLP-1 drugs like Ozempic to increased scurvy risk through appetite suppression and poor nutrition. University of Florida researchers are testing a GLP-1 implant for obese cats as feline obesity affects nearly 60% of US cats.